A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality. On average, it took eight ...
A recent report demonstrated that murine AK-5 tumor cells transiently upregulated FasL when grown in the peritoneal ... O'Sullivan, G.C., Collins, J.K. & Shanahan, F. The Fas counterattack ...
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality. On average, it took eight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback